Apellis Pharmaceuticals, Inc. reports

Company location: Waltham, MA
Fiscal year end: 31 December

Apellis Pharmaceuticals, Inc. has filed 1,229 SEC EDGAR filings since 21 May 2010

Filter by type:
10-K
10-Q
8-K
SC13G

SEC filing history

Showing 951-975 of 1,000 matching filings.

Per page

25

Current page

39

4

PRIMARY DOCUMENT

Filing date: 29 Jan 2021
Reporting date: 27 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 29 Jan 2021
Reporting date: 27 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38276

8-K

Filing date: 26 Jan 2021
Reporting date: 26 Jan 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 26 Jan 2021
Reporting date: 25 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 19 Jan 2021
Reporting date: 15 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 15 Jan 2021
Reporting date: 14 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38276

8-K

Filing date: 07 Jan 2021
Reporting date: 06 Jan 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 05 Jan 2021
Reporting date: 04 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 05 Jan 2021
Reporting date: 04 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 04 Jan 2021
Reporting date: 01 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 04 Jan 2021
Reporting date: 01 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 04 Jan 2021
Reporting date: 01 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 04 Jan 2021
Reporting date: 01 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 04 Jan 2021
Reporting date: 01 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38276

8-K

Filing date: 04 Jan 2021
Reporting date: 30 Dec 2020
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 23 Dec 2020
Reporting date: 23 Dec 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 16 Dec 2020
Reporting date: 15 Dec 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 16 Dec 2020
Reporting date: 15 Dec 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 15 Dec 2020
Reporting date: 14 Dec 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 15 Dec 2020
Reporting date: 11 Dec 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 09 Dec 2020
Reporting date: 08 Dec 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 08 Dec 2020
Reporting date: 04 Dec 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 08 Dec 2020
Reporting date: 04 Dec 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 07 Dec 2020
Reporting date: 04 Dec 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 02 Dec 2020
Reporting date: 01 Dec 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .